Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06501118 · ClinicalTrials.gov registry record · NA

Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

A NA study of Respiratory Failure and Hypoxia, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
3,600
Enrollment target
1
Study location

NCT06501118 is a NA study of Respiratory Failure and Hypoxia that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 3,600 participants, below the 4,434-participant average among 40 other Respiratory Failure trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06501118, a NA study of Respiratory Failure and Hypoxia, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
3,600 participants
Enrollment target
1
Study location

Study Summary

A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.

Interventions

  • OTHER Education
  • BEHAVIORAL Epic notification alert

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 3,600 participants
Start Date 2024-09-01
Est. Completion 2026-07-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT06501118

The ClinicalTrials.gov registry entry for NCT06501118 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,434-participant average among 40 other Respiratory Failure trials with a reported enrollment target (19% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT06501118 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06501118 about?

NCT06501118 is a clinical study titled "Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients". A multimodal educational intervention to target an oxygen saturation target range (SpO2 90-96%) will reduce ventilator length of stay and reduce occult hypoxemia by increased awareness and adherence to a designated oxygen saturation target range.

What is the current status of trial NCT06501118?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,600 participants. The study started on 2024-09-01. Estimated completion is 2026-07-31.

What conditions does trial NCT06501118 study?

This clinical trial studies the following conditions: Respiratory Failure, Hypoxia, Hypoxemia, Acute Hypoxemic Respiratory Failure, Acute Hypoxic Respiratory Failure.

What interventions are being tested in trial NCT06501118?

The interventions under investigation include: Education (OTHER), Epic notification alert (BEHAVIORAL).

Who is sponsoring clinical trial NCT06501118?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06501118 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.